Pharmacologie des dérivés du platine : différences entre les trois composés et les facteurs de variabilité entre patients-Reference-Cited by-同舟云学术

Pharmacologie des dérivés du platine : différences entre les trois composés et les facteurs de variabilité entre patients

Published:2011-11 Issue:11 Volume:98 Page:1253-1261
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Chatelut Étienne

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference21 articles.

1. Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance;Fuertes;Chem Rev,2003

2. Molecular mechanisms of resistance and toxicity associated with platinating agents;Rabik;Cancer Treat Rev,2007

3. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells;Song;Mol Cancer Ther,2004

4. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance;Rudin;Cancer Res,2003

5. Platinum resistance: the role of DNA repair pathways;Martin;Clin Cancer Res,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Au(III)- and Fe(III)-based complexes of bio-pharmacological interest: DFT and in silico studies;Theoretical Chemistry Accounts;2022-12-24

2. Ovarian Cancer: Treatment and Resistance to Pharmacotherapy;Reproductive Medicine;2022-05-09

3. Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review;Expert Opinion on Drug Metabolism & Toxicology;2020-10-02

4. The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer;Biomedicine & Pharmacotherapy;2020-09

5. Défaut de réparation de l’ADN : nouvelle piste thérapeutique pour le cancer de prostate métastatique;Bulletin du Cancer;2018-10